|
Cryolife, Inc. - Comparative Business Analysis Snapshot
Business Description
Cryolife, Inc.. The Group's principal activities are to develop and commercialize biomaterials, implantable medical devices. it also preserve and distribute human tissues for cardiovascular and vascular transplant applications. The Group operates in two segments: Implantable Medical Devices and Preservation Services. The Implantable medical devices segment includes the sales of BioGlue and bioprosthetic devices, including stentless porcine heart valves and SynerGraft processed bovine vascular grafts. The Preservation Services segment includes the preservation of cardiac, vascular, and orthopaedic allograft tissues. The Group's products are marketed in the United States, Europe, the Middle East, Canada, Australia and Asia.
Competitor Analysis
This analysis compares Cryolife, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
